scispace - formally typeset
G

Gabriel Lopez-Berestein

Researcher at University of Texas MD Anderson Cancer Center

Publications -  77
Citations -  7373

Gabriel Lopez-Berestein is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Liposome & Amphotericin B. The author has an hindex of 37, co-authored 77 publications receiving 7065 citations. Previous affiliations of Gabriel Lopez-Berestein include University of Texas Health Science Center at Houston & University of Texas System.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes

Daniel J. Klionsky, +235 more
- 16 Feb 2008 - 
TL;DR: A set of guidelines for the selection and interpretation of the methods that can be used by investigators who are attempting to examine macroautophagy and related processes, as well as by reviewers who need to provide realistic and reasonable critiques of papers that investigate these processes are presented.
Journal ArticleDOI

Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study

TL;DR: Twelve patients with hematologic malignancies complicated by fungal infections were treated with liposomal amphotericin B (L-AmpB); nine patients were granulocytopenic; the three additional patients with normal granulocyte counts were immunosuppressed.
Journal ArticleDOI

miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2

TL;DR: In this paper, the authors identify miR-34a as a critical suppressor of osteoclastogenesis, bone resorption and the bone metastatic niche, and propose a potential therapeutic strategy to confer skeletal protection and ameliorate bone metastasis of cancers.
Journal ArticleDOI

Treatment and Prophylaxis of Disseminated Infection Due to Candida albicans in Mice with Liposome-Encapsulated Amphotericin B

TL;DR: The encapsulated drug was as effective as the free drug when used in similar concentrations, while the animals treated with higher concentrations of liposomal amphotericin B had a longer survival time and an improved therapeutic index resulted by encapsulating amph esotericin B in liposomes.